Although photodynamic therapy (PDT) has promising advantages in almost non‐invasion,
low drug resistance, and low dark toxicity, it still suffers from limitations in the lipophilic …

Cancer remains as the major cause of death worldwide. The main reason why available
therapies fail is that a vicious cycle in established which initiates multiple pathways and …

Membrane-disruptive peptides/peptidomimetics (MDPs) are antimicrobials or
anticarcinogens that present a general killing mechanism through the physical disruption of …

The applications of nanoparticulate drug delivery have received abundant interest in the
field of cancer diagnosis and treatment. By virtue of their unique features and design …

Nanotherapy has emerged as an improved anticancer therapeutic strategy to circumvent the
harmful side effects of chemotherapy. It has been proven to be beneficial to offer multiple …

Purpose An AE147 peptide-conjugated nanocarrier based on PEGylated liposomes was
developed in order to target the metastatic tumors overexpressing urokinase-type …

Photoresponsive soft materials are everywhere in the nature, from human's retina tissues to
plants, and have been the inspiration for engineers in the development of modern …

Research in cancer therapy is moving towards the use of biomolecules in combination with
conventional approaches for improved disease outcome. Among the biomolecules explored …

Introduction Ligand-conjugated liposomes are promising for the treatment of specific
receptor-overexpressing cancers. However, previous studies have shown inconsistent …

Chlorin e6 (Ce6) and fullerene (C60) are among the most used photosensitizers (PSs) for
photodynamic therapy (PDT). Through the combination of the chemical and photophysical …